These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 6125363)
21. N-Dealkylation and hydroxylation of ebastine by human liver cytochrome P450. Hashizume T; Mise M; Terauchi Y; O L; Fujii T; Miyazaki H; Inaba T Drug Metab Dispos; 1998 Jun; 26(6):566-71. PubMed ID: 9616193 [TBL] [Abstract][Full Text] [Related]
22. Glucuronidation of propranolol by dog liver microsomes. Effects of enantiomeric inhibition and detergent treatment on stereoselectivity. Wilson BK; Thompson JA Drug Metab Dispos; 1984; 12(2):161-4. PubMed ID: 6144480 [TBL] [Abstract][Full Text] [Related]
23. Chemical trapping of labile aldehyde intermediates in the metabolism of propranolol and oxprenolol. Goldszer F; Tindell GL; Walle UK; Walle T Res Commun Chem Pathol Pharmacol; 1981 Nov; 34(2):193-205. PubMed ID: 7335950 [TBL] [Abstract][Full Text] [Related]
24. Species differences for stereoselective hydrolysis of propranolol prodrugs in plasma and liver. Yoshigae Y; Imai T; Horita A; Otagiri M Chirality; 1997; 9(7):661-6. PubMed ID: 9366026 [TBL] [Abstract][Full Text] [Related]
25. Fenproporex N-dealkylation to amphetamine--enantioselective in vitro studies in human liver microsomes as well as enantioselective in vivo studies in Wistar and Dark Agouti rats. Kraemer T; Pflugmann T; Bossmann M; Kneller NM; Peters FT; Paul LD; Springer D; Staack RF; Maurer HH Biochem Pharmacol; 2004 Sep; 68(5):947-57. PubMed ID: 15294457 [TBL] [Abstract][Full Text] [Related]
26. Proceedings: High-affinity hepatic microsomal binding of propranolol: its relationship to metabolism and to the first-pass effect. McEwen J; Shand DG; Wilkinson GR; Stevenson IH Br J Pharmacol; 1974 Sep; 52(1):140P-140P. PubMed ID: 4451791 [No Abstract] [Full Text] [Related]
27. Inhibition of aminopyrine demethylation and binding to cytochrome P-450 by its main metabolites in rat liver microsomes [proceedings]. Bast A; Noordhoek J Br J Pharmacol; 1980 Jan; 68(1):121P-122P. PubMed ID: 6766766 [No Abstract] [Full Text] [Related]
28. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes. Masubuchi Y; Kagimoto N; Narimatsu S; Fujita S; Suzuki T Drug Metab Dispos; 1993; 21(6):1012-6. PubMed ID: 7905378 [TBL] [Abstract][Full Text] [Related]
29. Interspecies differences in enantioselective mono-N-dealkylation of disopyramide by human and mouse liver microsomes. Echizen H; Mochizuki K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1994 Mar; 268(3):1518-25. PubMed ID: 8138963 [TBL] [Abstract][Full Text] [Related]
30. Biotransformation of 6-methoxy-3-(3',4',5'-trimethoxy-benzoyl)-1H-indole (BPR0L075), a novel antimicrotubule agent, by mouse, rat, dog, and human liver microsomes. Yao HT; Wu YS; Chang YW; Hsieh HP; Chen WC; Lan SJ; Chen CT; Chao YS; Chang L; Sun HY; Yeh TK Drug Metab Dispos; 2007 Jul; 35(7):1042-9. PubMed ID: 17403915 [TBL] [Abstract][Full Text] [Related]
31. In vitro identification of metabolites of verapamil in rat liver microsomes. Sun L; Zhang SQ; Zhong DF Acta Pharmacol Sin; 2004 Jan; 25(1):121-8. PubMed ID: 14704133 [TBL] [Abstract][Full Text] [Related]
32. Metabolism of N-alkyl compounds during the biosynthesis of prostaglandins. N-Dealkylation during prostaglandin biosynthesis. Sivarajah K; Lasker JM; Eling TE; Abou-Donia MB Mol Pharmacol; 1982 Jan; 21(1):133-41. PubMed ID: 6813675 [TBL] [Abstract][Full Text] [Related]
33. Stereoselectivity and interaction between the glucuronidation of S-(-)- and R-(+)-propranolol in rat hepatic microsomes pretreated with different inducers. Luan LJ; Shao Q; Zeng S Pharmazie; 2005 Mar; 60(3):221-4. PubMed ID: 15801678 [TBL] [Abstract][Full Text] [Related]
34. A potent inhibitory effect of erythromycin and other macrolide antibiotics on the mono-N-dealkylation metabolism of disopyramide with human liver microsomes. Echizen H; Kawasaki H; Chiba K; Tani M; Ishizaki T J Pharmacol Exp Ther; 1993 Mar; 264(3):1425-31. PubMed ID: 8450476 [TBL] [Abstract][Full Text] [Related]
35. Nonspecific binding to microsomes: impact on scale-up of in vitro intrinsic clearance to hepatic clearance as assessed through examination of warfarin, imipramine, and propranolol. Obach RS Drug Metab Dispos; 1997 Dec; 25(12):1359-69. PubMed ID: 9394025 [TBL] [Abstract][Full Text] [Related]
36. Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: molecular base for interaction potential and variable disposition of active metabolites. Botsch S; Gautier JC; Beaune P; Eichelbaum M; Kroemer HK Mol Pharmacol; 1993 Jan; 43(1):120-6. PubMed ID: 8423765 [TBL] [Abstract][Full Text] [Related]
37. Metabolism of roxithromycin in phenobarbital-treated rat liver microsomes. Zhong DF; Zhang SQ; Sun L; Zhao XY Acta Pharmacol Sin; 2002 May; 23(5):455-60. PubMed ID: 11978197 [TBL] [Abstract][Full Text] [Related]
38. Tolterodine, a new muscarinic receptor antagonist, is metabolized by cytochromes P450 2D6 and 3A in human liver microsomes. Postlind H; DanielsonA ; Lindgren A; Andersson SH Drug Metab Dispos; 1998 Apr; 26(4):289-93. PubMed ID: 9531513 [TBL] [Abstract][Full Text] [Related]
39. Catalyzation of cocaine N-demethylation by cytochromes P4502B, P4503A, and P4502D in fish liver. Arinç E; Bozcaarmutlu A J Biochem Mol Toxicol; 2003; 17(3):169-76. PubMed ID: 12815613 [TBL] [Abstract][Full Text] [Related]
40. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions. Labroo RB; Paine MF; Thummel KE; Kharasch ED Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]